Dose-Escalation Study of RRx-001 in Combination With Whole Brain Radiation in Subjects With Brain Metastases
Clinical trial NCT02215512 · COMPLETED
Trial details
- NCT number
- NCT02215512
- Sponsor
- EpicentRx, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-06
- Primary completion
- 2016-11-28
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.